267 related articles for article (PubMed ID: 19170597)
1. Metabolic oxidative cleavage of thioesters: evidence for the formation of sulfenic acid intermediates in the bioactivation of the antithrombotic prodrugs ticlopidine and clopidogrel.
Dansette PM; Libraire J; Bertho G; Mansuy D
Chem Res Toxicol; 2009 Feb; 22(2):369-73. PubMed ID: 19170597
[TBL] [Abstract][Full Text] [Related]
2. Formation and fate of a sulfenic acid intermediate in the metabolic activation of the antithrombotic prodrug prasugrel.
Dansette PM; Thébault S; Bertho G; Mansuy D
Chem Res Toxicol; 2010 Jul; 23(7):1268-74. PubMed ID: 20557086
[TBL] [Abstract][Full Text] [Related]
3. Thiolactone sulfoxides as new reactive metabolites acting as bis-electrophiles: implication in clopidogrel and prasugrel bioactivation.
Dansette PM; Levent D; Hessani A; Bertho G; Mansuy D
Chem Res Toxicol; 2013 May; 26(5):794-802. PubMed ID: 23527615
[TBL] [Abstract][Full Text] [Related]
4. Cytochromes P450 catalyze both steps of the major pathway of clopidogrel bioactivation, whereas paraoxonase catalyzes the formation of a minor thiol metabolite isomer.
Dansette PM; Rosi J; Bertho G; Mansuy D
Chem Res Toxicol; 2012 Feb; 25(2):348-56. PubMed ID: 22103858
[TBL] [Abstract][Full Text] [Related]
5. Bioactivation of clopidogrel and prasugrel: factors determining the stereochemistry of the thiol metabolite double bond.
Dansette PM; Levent D; Hessani A; Mansuy D
Chem Res Toxicol; 2015 Jun; 28(6):1338-45. PubMed ID: 25970225
[TBL] [Abstract][Full Text] [Related]
6. A possible mechanism for the differences in efficiency and variability of active metabolite formation from thienopyridine antiplatelet agents, prasugrel and clopidogrel.
Hagihara K; Kazui M; Kurihara A; Yoshiike M; Honda K; Okazaki O; Farid NA; Ikeda T
Drug Metab Dispos; 2009 Nov; 37(11):2145-52. PubMed ID: 19704027
[TBL] [Abstract][Full Text] [Related]
7. In vitro biotransformation studies of 2-oxo-clopidogrel: multiple thiolactone ring-opening pathways further attenuate prodrug activation.
Zhu Y; Zhou J
Chem Res Toxicol; 2013 Jan; 26(1):179-90. PubMed ID: 23249383
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic studies on the metabolic scission of thiazolidinedione derivatives to acyclic thiols.
Reddy VB; Karanam BV; Gruber WL; Wallace MA; Vincent SH; Franklin RB; Baillie TA
Chem Res Toxicol; 2005 May; 18(5):880-8. PubMed ID: 15892582
[TBL] [Abstract][Full Text] [Related]
9. Multiple cytochrome P450 isoforms are involved in the generation of a pharmacologically active thiol metabolite, whereas paraoxonase 1 and carboxylesterase 1 catalyze the formation of a thiol metabolite isomer from ticlopidine.
Kim MJ; Jeong ES; Park JS; Lee SJ; Ghim JL; Choi CS; Shin JG; Kim DH
Drug Metab Dispos; 2014 Jan; 42(1):141-52. PubMed ID: 24170778
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of capsaicin by cytochrome P450 produces novel dehydrogenated metabolites and decreases cytotoxicity to lung and liver cells.
Reilly CA; Ehlhardt WJ; Jackson DA; Kulanthaivel P; Mutlib AE; Espina RJ; Moody DE; Crouch DJ; Yost GS
Chem Res Toxicol; 2003 Mar; 16(3):336-49. PubMed ID: 12641434
[TBL] [Abstract][Full Text] [Related]
11. Comparison of formation of thiolactones and active metabolites of prasugrel and clopidogrel in rats and dogs.
Hagihara K; Kazui M; Ikenaga H; Nanba T; Fusegawa K; Takahashi M; Kurihara A; Okazaki O; Farid NA; Ikeda T
Xenobiotica; 2009 Mar; 39(3):218-26. PubMed ID: 19280520
[TBL] [Abstract][Full Text] [Related]
12. Investigation of bioactivation of ticlopidine using linear ion trap/orbitrap mass spectrometry and an improved mass defect filtering technique.
Ruan Q; Zhu M
Chem Res Toxicol; 2010 May; 23(5):909-17. PubMed ID: 20297803
[TBL] [Abstract][Full Text] [Related]
13. Metabolic activation of prasugrel: nature of the two competitive pathways resulting in the opening of its thiophene ring.
Dansette PM; Rosi J; Debernardi J; Bertho G; Mansuy D
Chem Res Toxicol; 2012 May; 25(5):1058-65. PubMed ID: 22482514
[TBL] [Abstract][Full Text] [Related]
14. Bioactivation of tetrachloroethylene. Role of glutathione S-transferase-catalyzed conjugation versus cytochrome P-450-dependent phospholipid alkylation.
Dekant W; Martens G; Vamvakas S; Metzler M; Henschler D
Drug Metab Dispos; 1987; 15(5):702-9. PubMed ID: 2891489
[TBL] [Abstract][Full Text] [Related]
15. Characterization of novel dihydrothienopyridinium and thienopyridinium metabolites of ticlopidine in vitro: role of peroxidases, cytochromes p450, and monoamine oxidases.
Dalvie DK; O'Connell TN
Drug Metab Dispos; 2004 Jan; 32(1):49-57. PubMed ID: 14709620
[TBL] [Abstract][Full Text] [Related]
16. A novel bioactivation pathway for 2-[2-(2,6-dichlorophenyl)aminophenyl]ethanoic acid (diclofenac) initiated by cytochrome P450-mediated oxidative decarboxylation.
Grillo MP; Ma J; Teffera Y; Waldon DJ
Drug Metab Dispos; 2008 Sep; 36(9):1740-4. PubMed ID: 18541695
[TBL] [Abstract][Full Text] [Related]
17. Bioactivation of the tricyclic antidepressant amitriptyline and its metabolite nortriptyline to arene oxide intermediates in human liver microsomes and recombinant P450s.
Wen B; Ma L; Zhu M
Chem Biol Interact; 2008 May; 173(1):59-67. PubMed ID: 18359012
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of ticlopidine in rats: identification of the main biliary metabolite as a glutathione conjugate of ticlopidine S-oxide.
Shimizu S; Atsumi R; Nakazawa T; Fujimaki Y; Sudo K; Okazaki O
Drug Metab Dispos; 2009 Sep; 37(9):1904-15. PubMed ID: 19541827
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites.
Avent KM; DeVoss JJ; Gillam EM
Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959
[TBL] [Abstract][Full Text] [Related]
20. Trimethoprim: novel reactive intermediates and bioactivation pathways by cytochrome p450s.
Damsten MC; de Vlieger JS; Niessen WM; Irth H; Vermeulen NP; Commandeur JN
Chem Res Toxicol; 2008 Nov; 21(11):2181-7. PubMed ID: 18816075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]